Licensing contracts have given e-clinical solutions provider OmniComm a big first-half boost. The company reports a 51 percent increase in new tech-transfer licenses over first-half 2009, surpassing $6.9 million. Such licensing accounts for 70 percent of new business while it represents 44 percent for the company's business overall.
Software-as-a-service contracts have shown a "steady increase," according to a statement. The company says also that it has "seen some signs of increased spending in the clinical trial R&D arena."
Omnicomm maintains a roughly even presence in life sciences sectors, including biotech, academic/research, CRO, medical device, and pharma.
- see the Omnicomm earnings release